articleTop 1% cited
A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy
AIDS · 2000 · Vol. 14(9) · pp. F83–F93
John D. Baxter✉(United States Army Medical Command)Douglas L. Mayers(United States Army Medical Command)Deborah Wentworth(United States Army Medical Command)James D. Neaton(United States Army Medical Command)Marie L. Hoover(United States Army Medical Command)Mark A. Winters(United States Army Medical Command)Sharon Mannheimer(United States Army Medical Command)Melanie Thompson(United States Army Medical Command)Donald I. Abrams(United States Army Medical Command)Barbara Brizz(United States Army Medical Command)John P. A. Ioannidis(United States Army Medical Command)Thomas C. Merigan(United States Army Medical Command)
Abstract
In patients failing triple drug therapy, GART with expert advice was superior to no-GART as measured by short-term viral load responses.
HIV/AIDS drug development and treatmentHIV Research and TreatmentHIV/AIDS Research and InterventionsIndinavirMedicineNelfinavirSaquinavirInternal medicineRitonavirRandomizationConfidence intervalRandomized controlled trialSida
MeSH terms
Acquired Immunodeficiency SyndromeAdultDrug Resistance, MicrobialDrug Therapy, CombinationFemaleGenotypeHumansMaleMutationRNA, ViralHIV-1HIV InfectionsHIV Protease InhibitorsCD4 Lymphocyte CountAnti-HIV Agents
Citations
502
FWCI
44.18
field-weighted impact
References
18
Percentile
100%
vs. same field & year
Citations per year
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.